Clinitech Laboratory Limited Enhances Services with New In-House Molecular Testing Department
Clinitech Laboratory Limited has announced the introduction of an in-house molecular department for all tests, enhancing its medical services. This strategic move aims to improve diagnostic capabilities, potentially offering faster turnaround times, better quality control, and a more comprehensive service offering for patients. The expansion aligns with industry trends towards integrated and advanced diagnostic services, potentially strengthening Clinitech's market position.